Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$2.64 - $4.35 $315,099 - $519,198
119,356 New
119,356 $336,000
Q3 2023

Nov 14, 2023

BUY
$3.65 - $6.9 $438,697 - $829,317
120,191 Added 214.73%
176,165 $667,000
Q2 2023

Aug 14, 2023

BUY
$3.5 - $5.67 $195,909 - $317,372
55,974 New
55,974 $307,000
Q2 2021

Aug 16, 2021

SELL
$24.34 - $38.34 $13.9 Million - $21.9 Million
-571,705 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$24.74 - $40.2 $42.9 Million - $69.7 Million
-1,732,628 Reduced 75.19%
571,705 $16.3 Million
Q4 2020

Feb 12, 2021

SELL
$21.68 - $51.61 $3.96 Million - $9.43 Million
-182,805 Reduced 7.35%
2,304,333 $65.3 Million
Q3 2020

Nov 16, 2020

BUY
$18.07 - $31.84 $7.51 Million - $13.2 Million
415,826 Added 20.08%
2,487,138 $76.3 Million
Q2 2020

Aug 14, 2020

BUY
$20.1 - $24.69 $41.6 Million - $51.1 Million
2,071,312 New
2,071,312 $42.6 Million

Others Institutions Holding GBIO

About Generation Bio Co.


  • Ticker GBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,011,200
  • Market Cap $79.7M
  • Description
  • Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...
More about GBIO
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.